Recent review of COVID-19 management: Diagnosis, treatment and vaccination

VP Chavda, S Vuppu, T Mishra, S Kamaraj… - Pharmacological …, 2022 - Springer
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …

[HTML][HTML] Role of machine learning techniques to tackle the COVID-19 crisis: systematic review

HB Syeda, M Syed, KW Sexton, S Syed… - JMIR medical …, 2021 - medinform.jmir.org
Background: SARS-CoV-2, the novel coronavirus responsible for COVID-19, has caused
havoc worldwide, with patients presenting a spectrum of complications that have pushed …

[HTML][HTML] Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing …

YW Chen, CPB Yiu, KY Wong - F1000Research, 2020 - ncbi.nlm.nih.gov
We prepared the three-dimensional model of the SARS-CoV-2 (aka 2019-nCoV) 3C-like
protease (3CL pro) using the crystal structure of the highly similar (96% identity) ortholog …

The recent technologies to curb the second-wave of COVID-19 pandemic

M Poongodi, M Malviya, M Hamdi, HT Rauf… - Ieee …, 2021 - ieeexplore.ieee.org
Different epidemics, specially Coronavirus, have caused critical misfortunes in various fields
like monetary deprivation, survival conditions, thus diminishing the overall individual …

Corona virus disease 2019

D Handayani, DR Hadi, F Isbaniah… - Jurnal Respirologi …, 2020 - jurnalrespirologi.org
Abstract Corona virus disease 2019 (COVID-19) is a new name given by World Health
Organization (WHO) of 2019 novel corona virus infection, reported at the end of 2019 from …

[HTML][HTML] Genotyping coronavirus SARS-CoV-2: methods and implications

C Yin - Genomics, 2020 - Elsevier
The emerging global infectious COVID-19 disease by novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and …

Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro

H Liu, F Ye, Q Sun, H Liang, C Li, S Li… - Journal of enzyme …, 2021 - Taylor & Francis
COVID-19 has become a global pandemic and there is an urgent call for developing drugs
against the virus (SARS-CoV-2). The 3C-like protease (3CLpro) of SARS-CoV-2 is a …

Blockchain and AI-based solutions to combat coronavirus (COVID-19)-like epidemics: A survey

DC Nguyen, M Ding, PN Pathirana… - Ieee Access, 2021 - ieeexplore.ieee.org
The beginning of 2020 has seen the emergence of coronavirus outbreak caused by a novel
virus called SARS-CoV-2. The sudden explosion and uncontrolled worldwide spread of …

[HTML][HTML] Immunology of COVID-19: current state of the science

N Vabret, GJ Britton, C Gruber, S Hegde, J Kim… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …

Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds

A Fischer, M Sellner, S Neranjan, M Smieško… - International journal of …, 2020 - mdpi.com
The rapid outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in China followed by its spread around the world poses a serious global concern for …